NA
Nascent Pharma Holdings, Inc.
NASC · OTC
$0.01 +0.00% (+$0.00)
1M +8.87%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
56 /100
Moderate EPS volatility 15.06%
Beta 0.61x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NASC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marco Alfonsi
Employees
12
Headquarters
Hicksville
Upcoming events
06 NOV
Earnings
Upcoming earnings report